Clinical Trials Browser

Phase 2 × Recurrent Uterine Corpus Sarcoma × Granulocyte Colony-Stimulating Factor × Clear all

NCT00031629 2016-12-08

Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Phase 2 Completed

GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma